The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs
- PMID: 2826116
- DOI: 10.1210/endo-122-1-97
The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs
Abstract
The role of ACTH in the cortisol and aldosterone responses to iv angiotensin II (AII) infusion, (5, 10, and 20 ng kg-1 min-1) in dogs was evaluated by examining the effect of AII infusion in conscious dogs pretreated with dexamethasone to suppress endogenous ACTH secretion. AII infusion in untreated dogs produced dose-related increases in plasma cortisol and aldosterone concentrations. The plasma ACTH concentration also increased. Dexamethasone treatment lowered the basal cortisol concentration from 1.7 +/- 0.1 to 0.7 +/- 0.1 micrograms/dl (P less than 0.05) and the ACTH concentration from 52 +/- 3 to 41 +/- 4 pg/ml (P less than 0.05), and abolished the cortisol response to all doses of AII, indicating that ACTH was necessary for the response. On the other hand, the basal aldosterone concentration was not significantly affected by dexamethasone, although the aldosterone response to the highest dose of AII was reduced. Additional experiments were performed to determine if the cortisol and aldosterone responses to AII (20 ng kg-1 min-1) in dexamethasone-treated dogs are restored if the ACTH concentration is maintained near control levels by iv infusion of synthetic alpha ACTH-(1-24) (0.3 ng kg-1 min-1). AII still failed to increase the plasma cortisol concentration in this group of dogs; however, the aldosterone response was fully restored. To evaluate the effect of elevated ACTH levels on the steroidogenic effects of AII, dogs were treated with dexamethasone and a higher dose of ACTH (0.4 ng kg-1 min-1). This dose of ACTH increased the plasma cortisol concentration from 1.7 +/- 0.1 to 3.5 +/- 0.8 micrograms/dl (P less than 0.05), but did not significantly affect the plasma aldosterone concentration. In the presence of constant elevated levels of ACTH, AII (10 and 20 ng kg-1 min-1) increased the plasma cortisol concentration in dexamethasone-treated dogs, although the response to the 10 ng kg-1 min-1 dose was smaller than the response in untreated dogs. Infusion of AII at 5 ng kg-1 min-1 did not increase the plasma cortisol concentration. In contrast, the increased plasma aldosterone produced by AII infusion in dexamethasone-treated dogs was not altered in the presence of elevated ACTH levels. Finally, AII infusion did not alter the clearance of cortisol. Collectively, these results demonstrate that an increase in plasma ACTH is necessary for the cortisol response to AII infusion.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Differential effects of atrial natriuretic factor on angiotensin II- and adrenocorticotropin-stimulated aldosterone secretion.Endocrinology. 1987 Jan;120(1):299-304. doi: 10.1210/endo-120-1-299. Endocrinology. 1987. PMID: 3023030
-
Diminished aldosterone responses to angiotensin II and adrenocorticotropin in hypocalcemic subjects: restoration of responsiveness with normocalcemia.J Clin Endocrinol Metab. 1987 Feb;64(2):297-303. doi: 10.1210/jcem-64-2-297. J Clin Endocrinol Metab. 1987. PMID: 3025245
-
Dose effect of adrenocorticotropin on aldosterone and cortisol biosynthesis in cultured bovine adrenal glomerulosa cells: in vitro correlate of hyperreninemic hypoaldosteronism.Endocrinology. 1992 Jul;131(1):187-94. doi: 10.1210/endo.131.1.1319318. Endocrinology. 1992. PMID: 1319318
-
The role of angiotensin II in the regulation of ACTH secretion.Ann N Y Acad Sci. 1987;512:176-86. doi: 10.1111/j.1749-6632.1987.tb24959.x. Ann N Y Acad Sci. 1987. PMID: 2831773 Review.
-
Examining aldosterone plasma concentration alterations post-ACTH stimulation in healthy subjects: a systematic literature review and meta-analysis on ACTH's role in aldosterone secretion.Hormones (Athens). 2024 Dec;23(4):765-775. doi: 10.1007/s42000-024-00583-6. Epub 2024 Jul 25. Hormones (Athens). 2024. PMID: 39052132
Cited by
-
Exaggerated sympathetic mediated responses to behavioral or pharmacological challenges following antenatal betamethasone exposure.Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E979-85. doi: 10.1152/ajpendo.00636.2010. Epub 2011 Mar 8. Am J Physiol Endocrinol Metab. 2011. PMID: 21386063 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous